Compare UCTT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UCTT | AMPH |
|---|---|---|
| Founded | 1991 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2004 | 2014 |
| Metric | UCTT | AMPH |
|---|---|---|
| Price | $26.08 | $27.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $32.50 | $31.00 |
| AVG Volume (30 Days) | ★ 511.6K | 380.2K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.27 |
| Revenue | ★ $2,110,600,000.00 | $723,305,000.00 |
| Revenue This Year | N/A | $1.35 |
| Revenue Next Year | $5.74 | $5.10 |
| P/E Ratio | ★ N/A | $11.95 |
| Revenue Growth | ★ 6.65 | N/A |
| 52 Week Low | $16.66 | $20.39 |
| 52 Week High | $40.10 | $39.01 |
| Indicator | UCTT | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 55.26 |
| Support Level | $25.57 | $26.26 |
| Resistance Level | $26.42 | $27.44 |
| Average True Range (ATR) | 1.04 | 0.82 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 45.21 | 83.33 |
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.